BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34521918)

  • 1. Hypoxia increases KIAA1199/CEMIP expression and enhances cell migration in pancreatic cancer.
    Oba T; Sato N; Adachi Y; Amaike T; Kudo Y; Koga A; Kohi S; Hirata K
    Sci Rep; 2021 Sep; 11(1):18193. PubMed ID: 34521918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
    Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of transmembrane protein 2 (TMEM2), a novel hyaluronidase, predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Kudo Y; Sato N; Adachi Y; Amaike T; Koga A; Kohi S; Noguchi H; Nakayama T; Hirata K
    Pancreatology; 2020 Oct; 20(7):1479-1485. PubMed ID: 32948431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer.
    Kohi S; Sato N; Koga A; Matayoshi N; Hirata K
    Oncotarget; 2017 Mar; 8(10):17156-17163. PubMed ID: 28179576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HYBID (alias KIAA1199/CEMIP) and hyaluronan synthase coordinately regulate hyaluronan metabolism in histamine-stimulated skin fibroblasts.
    Yoshida H; Aoki M; Komiya A; Endo Y; Kawabata K; Nakamura T; Sakai S; Sayo T; Okada Y; Takahashi Y
    J Biol Chem; 2020 Feb; 295(8):2483-2494. PubMed ID: 31949043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent Overexpression of Two Hyaluronidases, KIAA1199 and TMEM2, Strongly Predicts Shorter Survival After Resection in Pancreatic Ductal Adenocarcinoma.
    Kudo Y; Sato N; Oba T; Adachi Y; Amaike T; Koga A; Kohi S; Noguchi H; Nakayama T; Hirata K
    Pancreas; 2022 Aug; 51(7):800-807. PubMed ID: 36395406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression.
    Gao C; Li S; Zhao T; Chen J; Ren H; Zhang H; Wang X; Lang M; Liu J; Gao S; Zhao X; Sheng J; Yuan Z; Hao J
    PLoS One; 2015; 10(3):e0121338. PubMed ID: 25799412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-molecular-weight hyaluronan produced by activated pancreatic stellate cells promotes pancreatic cancer cell migration via paracrine signaling.
    Junliang L; Lili W; Xiaolong L; Xuguang L; Huanwen W; Zhiyong L
    Biochem Biophys Res Commun; 2019 Jul; 515(3):493-498. PubMed ID: 31171359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Expression of HYAL1 in Pancreatic Ductal Adenocarcinoma.
    Kohi S; Sato N; Cheng XB; Koga A; Hirata K
    Pancreas; 2016 Nov; 45(10):1467-1473. PubMed ID: 27622341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of PHD3 represses the HIF-1 signaling pathway and contributes to poor neovascularization in pancreatic ductal adenocarcinoma.
    Tanaka T; Li TS; Urata Y; Goto S; Ono Y; Kawakatsu M; Matsushima H; Hirabaru M; Adachi T; Kitasato A; Takatsuki M; Kuroki T; Eguchi S
    J Gastroenterol; 2015 Sep; 50(9):975-83. PubMed ID: 25542265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma.
    Kudo Y; Kohi S; Hirata K; Goggins M; Sato N
    Oncotarget; 2019 Sep; 10(54):5592-5604. PubMed ID: 31608136
    [No Abstract]   [Full Text] [Related]  

  • 12. Co-expression of KIAA1199 and hypoxia-inducible factor 1α is a biomarker for an unfavorable prognosis in hepatocellular carcinoma.
    Wang D; Lu S; Zhang X; Huang L; Zhao H
    Medicine (Baltimore); 2020 Dec; 99(50):e23369. PubMed ID: 33327261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP).
    Evensen NA; Li Y; Kuscu C; Liu J; Cathcart J; Banach A; Zhang Q; Li E; Joshi S; Yang J; Denoya PI; Pastorekova S; Zucker S; Shroyer KR; Cao J
    Oncotarget; 2015 Aug; 6(24):20723-39. PubMed ID: 26009875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human TMEM2 is not a catalytic hyaluronidase, but a regulator of hyaluronan metabolism via HYBID (KIAA1199/CEMIP) and HAS2 expression.
    Sato S; Miyazaki M; Fukuda S; Mizutani Y; Mizukami Y; Higashiyama S; Inoue S
    J Biol Chem; 2023 Jun; 299(6):104826. PubMed ID: 37196767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forced expression of KIAA1199, a novel hyaluronidase, inhibits tumorigenicity of low-grade chondrosarcoma.
    Koike H; Nishida Y; Shinomura T; Zhuo L; Hamada S; Ikuta K; Ito K; Kimata K; Ushida T; Ishiguro N
    J Orthop Res; 2020 Sep; 38(9):1942-1951. PubMed ID: 32068299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan stimulates pancreatic cancer cell motility.
    Cheng XB; Kohi S; Koga A; Hirata K; Sato N
    Oncotarget; 2016 Jan; 7(4):4829-40. PubMed ID: 26684359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
    Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
    Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation between the expression levels of receptor for hyaluronic acid-mediated motility and hyaluronan leads to cell migration in pancreatic cancer.
    Cheng XB; Wang S; Yang H; Tong H; Shi G; Wu L; Zhou J; Shi L; Li H; Ren S; Zhou Y; Sato N
    Oncol Lett; 2020 Nov; 20(5):199. PubMed ID: 32963605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sauchinone inhibits hypoxia-induced epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma cells through the Wnt/β-catenin pathway.
    Qiao Y; Yan LJ; Yan C
    Anticancer Drugs; 2020 Oct; 31(9):918-924. PubMed ID: 32889895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF1α lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer.
    Luo Y; Yang Z; Yu Y; Zhang P
    Int J Biol Macromol; 2022 Dec; 222(Pt B):2225-2243. PubMed ID: 36209908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.